Integrating functional marrow reserve and molecular risk improves prediction of post-transplant outcomes in HMA-treated myelodysplastic syndromes
- DOI
- 10.1016/j.bneo.2026.100275
- Published
- 2026-11
- Container
- Blood Neoplasia
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.bneo.2026.100275,
title = {Integrating functional marrow reserve and molecular risk improves prediction of post-transplant outcomes in HMA-treated myelodysplastic syndromes},
author = {Luis E. Aguirre and Haesook T. Kim and Hany Elmariah and Stacey M. Frumm and Amar H. Kelkar and Vincent Ho and Mahasweta Gooptu and John Koreth and Roman M. Shapiro and Rizwan Romee and Sarah Nikiforow and Joseph H. Antin and Robert J. Soiffer and Shai Shimony and Marlise R. Luskin and Jacqueline S. Garcia and Evan C. Chen and Martha Wadleigh and Eric S. Winer and Richard M. Stone and Daniel J. DeAngelo and Najla Al Ali and David Sallman and Andrew Kuykendall and Kendra Sweet and Jeffrey E. Lancet and Eric Padron and Onyee Chan and Zhuoer Xie and Corey S. Cutler and Maximilian Stahl and Rami S. Komrokji},
year = {2026},
journal = {Blood Neoplasia},
doi = {10.1016/j.bneo.2026.100275},
url = {https://doi.org/10.1016/j.bneo.2026.100275}
}RIS
TY - JOUR TI - Integrating functional marrow reserve and molecular risk improves prediction of post-transplant outcomes in HMA-treated myelodysplastic syndromes AU - Luis E. Aguirre AU - Haesook T. Kim AU - Hany Elmariah AU - Stacey M. Frumm AU - Amar H. Kelkar AU - Vincent Ho AU - Mahasweta Gooptu AU - John Koreth AU - Roman M. Shapiro AU - Rizwan Romee AU - Sarah Nikiforow AU - Joseph H. Antin AU - Robert J. Soiffer AU - Shai Shimony AU - Marlise R. Luskin AU - Jacqueline S. Garcia AU - Evan C. Chen AU - Martha Wadleigh AU - Eric S. Winer AU - Richard M. Stone AU - Daniel J. DeAngelo AU - Najla Al Ali AU - David Sallman AU - Andrew Kuykendall AU - Kendra Sweet AU - Jeffrey E. Lancet AU - Eric Padron AU - Onyee Chan AU - Zhuoer Xie AU - Corey S. Cutler AU - Maximilian Stahl AU - Rami S. Komrokji PY - 2026 JO - Blood Neoplasia DO - 10.1016/j.bneo.2026.100275 UR - https://doi.org/10.1016/j.bneo.2026.100275 ER -
APA
Aguirre, L. E., Kim, H. T., Elmariah, H., Frumm, S. M., Kelkar, A. H., Ho, V., Gooptu, M., Koreth, J., Shapiro, R. M., Romee, R., Nikiforow, S., Antin, J. H., Soiffer, R. J., Shimony, S., Luskin, M. R., Garcia, J. S., Chen, E. C., Wadleigh, M., Winer, E. S., Stone, R. M., DeAngelo, D. J., Ali, N. A., Sallman, D., Kuykendall, A., Sweet, K., Lancet, J. E., Padron, E., Chan, O., Xie, Z., Cutler, C. S., Stahl, M., & Komrokji, R. S. (2026). Integrating functional marrow reserve and molecular risk improves prediction of post-transplant outcomes in HMA-treated myelodysplastic syndromes. Blood Neoplasia. https://doi.org/10.1016/j.bneo.2026.100275
Source records
- crossref · retrieved 2026-11-08T11:30:02.271Z